Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 17,5 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 17,5 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 17,5 mg

Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 30 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 30 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 30 mg

Metoject Stungulyf, lausn í áfylltri sprautu 50 mg/ml Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metoject stungulyf, lausn í áfylltri sprautu 50 mg/ml

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltri sprautu - 50 mg/ml

Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 10 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 10 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 10 mg

Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 12,5 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 12,5 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 12,5 mg

Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 15 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 15 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 15 mg

Metojectpen (Metoject) Stungulyf, lausn í áfylltum lyfjapenna 22,5 mg Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

metojectpen (metoject) stungulyf, lausn í áfylltum lyfjapenna 22,5 mg

medac gesellschaft für klinische spezialpräparate gmbh - methotrexatum inn - stungulyf, lausn í áfylltum lyfjapenna - 22,5 mg

Zoledronic acid medac Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

zoledronic acid medac

medac gesellschaft für klinische spezialpräparate mbh - zoledronsýru einhýdrat - fractures, bone; cancer - lyf til að meðhöndla beinsjúkdóma - forvarnir vegna tengdra beinagrindar (sjúkdómsbrot, mænuþrýstingur, geislun eða skurðaðgerð í bein eða æxlisfrumna blóðkalsíumhækkun) hjá fullorðnum sjúklingum með langt gengið illkynja sjúkdóma sem fela í sér bein. meðferð fullorðinn sjúklinga með æxli völdum álíka (tih).

Carmustine medac (previously Carmustine Obvius) Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

carmustine medac (previously carmustine obvius)

medac gesellschaft für klinische spezialpräparate mbh - carmustine - hodgkin disease; lymphoma, non-hodgkin - Æxlishemjandi lyf - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

BCG-medac Duft og leysir fyrir þvagblöðrudreifu Iceland - Iceland - LYFJASTOFNUN (Icelandic Medicines Agency)

bcg-medac duft og leysir fyrir þvagblöðrudreifu

medac gesellschaft für klinische spezialpräparate gmbh - bcg bacteria - duft og leysir fyrir þvagblöðrudreifu